Showing 68,121 - 68,140 results of 104,605 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 5 ((mean decrease) OR (a decrease)) ))', query time: 1.25s Refine Results
  1. 68121
  2. 68122

    Image_1_Characteristics of steroid hormones in systemic lupus erythematosus revealed by GC/MS-based metabolic profiling.tif by Dehong Wu (2236318)

    Published 2023
    “…Principle component analysis demonstrated that the steroid profile was obviously distinguished between patients with SLE and controls. A lower level of total androgens was observed in patients, and nine androgens [dehydroepiandrosterone (DHEA), testosterone, Etio, androsterone, βαβ-Diol, Epi-An, Epi-DHT, 16α-OH-DHEA, and A-Diol] underwent significant decrease. …”
  3. 68123

    DataSheet1_Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment.ZIP by Ruiming Zhang (3555281)

    Published 2024
    “…<p>Background: Chrysin (5,7-dihydroxyflavone) is a natural flavonoid that has been reported as a potential treatment for non-alcoholic fatty liver disease (NAFLD). …”
  4. 68124

    DataSheet2_Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment.docx by Ruiming Zhang (3555281)

    Published 2024
    “…<p>Background: Chrysin (5,7-dihydroxyflavone) is a natural flavonoid that has been reported as a potential treatment for non-alcoholic fatty liver disease (NAFLD). …”
  5. 68125

    Longitudinal serum nAb mapping. by Tysheena P. Charles (3385586)

    Published 2021
    “…Red shading indicates a log fold reduction of 0.5log10 of greater; green shading indicates a log fold increase of 05.log10 or greater. …”
  6. 68126

    Table_1_Exercise-Induced Plasma Metabolomic Profiles in Patients With Peripheral Arterial Disease.pdf by Wendsèndaté Yves Semporé (11722121)

    Published 2021
    “…The best discriminant metabolites contributing to the model included a subset of 71 (47%) of the 150 accurately measured metabolites in the plasma, comprising 3 acylcarnitines, 3 amino acids, 5 biogenic amines, 9 sphingomyelin, 7 lysophosphatidylcholines, and 44 phosphatidylcholines. …”
  7. 68127

    Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All by Joke Bilcke (262673)

    Published 2014
    “…The disease and economic burden were similar for ambulatory ILI patients, irrespective of whether they received a clinical diagnosis of flu. On average, they experienced 5–6 symptoms over a 6-day period; required 1.6 physician visits and 86–91% took medication. …”
  8. 68128

    Temporal Trends and Outcomes of Transcatheter versus Surgical Aortic Valve Replacement in Patients with Prior Myocardial Infarction by Ayman Elbadawi (4788270)

    Published 2020
    “…</p> <p><b>Results</b><b>:</b> Among 24,090 hospitalizations with prior MI undergoing isolated AVR, 58.5% underwent TAVR. Over the study period, there was an increase in the proportion of patients undergoing TAVR and a decrease in patients undergoing SAVR (P<sub>trend</sub><0.001). …”
  9. 68129

    Comparison of the major phyla of the gut microbiota before and after smoking cessation. by Luc Biedermann (139959)

    Published 2013
    “…Whereas the intervention group revealed a significant increase in fractions of <i>Firmicutes</i> and <i>Actinobacteria</i> and a decrease in fractions of <i>Proteobacteria</i> and <i>Bacteroidetes</i>, the microbiota of the control groups remained rather stable. …”
  10. 68130

    Cell growth, cell viability and programmed cell death following oseltamivir treatment. by Joana T. de Oliveira (718565)

    Published 2015
    “…<p>Cell growth assessed with Trypan blue (A) or with the MTS assay (B) and programmed cell death (C) were evaluated in CMA07 and CMT-U27 cells following treatment with oseltamivir phosphate (0.305 μM, 3.05 μM, 30.5 μM and 305 μM) or PBS as control. …”
  11. 68131

    Table_2_Exercise-Induced Plasma Metabolomic Profiles in Patients With Peripheral Arterial Disease.pdf by Wendsèndaté Yves Semporé (11722121)

    Published 2021
    “…The best discriminant metabolites contributing to the model included a subset of 71 (47%) of the 150 accurately measured metabolites in the plasma, comprising 3 acylcarnitines, 3 amino acids, 5 biogenic amines, 9 sphingomyelin, 7 lysophosphatidylcholines, and 44 phosphatidylcholines. …”
  12. 68132

    MuSK patient IgG4 or IgG1-3 do not induce endocytosis of MuSK. by Inga Koneczny (481353)

    Published 2013
    “…(B) Staining was scored by two individuals as described in methods, and the scores were normalised to the score at 0 hours for each condition. A slight decrease in staining was observed for cells incubated at 37°C, and pre-fixed cells also showed this reduction. …”
  13. 68133

    Supplementary Material for: Improved Control of Secondary Hyperparathyroidism in Hemodialysis Patients Switching from Oral Cinacalcet to Intravenous Etelcalcetide, Especially in No... by Xipell M. (6276968)

    Published 2019
    “…The adherent group (62%) also showed a trend to lower iPTH levels reaching statistical significance after 5 months of follow-up. …”
  14. 68134

    Rapid chemical de-N-glycosylation and derivatization for liquid chromatography of immunoglobulin N-linked glycans by Akihiko Kameyama (2033902)

    Published 2018
    “…Considering this balance, we proposed to carry out the reaction at 80°C for 1 h for asialo glycoproteins from mammals and at 50°C for 1 h for sialoglycoproteins.…”
  15. 68135
  16. 68136
  17. 68137
  18. 68138

    Evaluation of platelet dense granules by transmission electron microscopy in healthy pediatric donors and pediatric patients with suspected platelet disorders by Jacob R. Greenmyer (11252672)

    Published 2025
    “…</p> <p>Healthy donors (<i>n</i> = 77, 41.6% female), ages 3–18 years, had a mean of 2.7 DG/platelet (±0.5), ranging from 1.9 to 3.8 per platelet. …”
  19. 68139

    Region D is transactivated by ETS and GATA factors. by Alexandra Le Bras (243728)

    Published 2010
    “…The −252/+38 promoter region responds to Ets-1, Erg and Fli-1 and mutation of EBS5 abolished the response to the ETS factors. Mutation of either EBS3 or of EBS4 had no effect on the response to Ets-1 or to Fli-1, however, mutation of EBS3 increased the response to Erg, that of EBS4 decreased it, *** p<0.001, ** p<0.01, * p<0.05.…”
  20. 68140

    CD20-TCB induces resident T cell proliferation and recruitment of peripheral blood T cells. by Floriana Cremasco (5580266)

    Published 2021
    “…<p>a-c) Top: Representative histological staining of WSU DLCL2 tumors 24h post second treatment (0.5 mg/kg CD20-TCB or suitable vehicle i.v.). …”